SE9904132D0 - Pharmaceutical composition for treatment of diarrhea - Google Patents

Pharmaceutical composition for treatment of diarrhea

Info

Publication number
SE9904132D0
SE9904132D0 SE9904132A SE9904132A SE9904132D0 SE 9904132 D0 SE9904132 D0 SE 9904132D0 SE 9904132 A SE9904132 A SE 9904132A SE 9904132 A SE9904132 A SE 9904132A SE 9904132 D0 SE9904132 D0 SE 9904132D0
Authority
SE
Sweden
Prior art keywords
cysteine
diarrhea
pharmaceutical composition
treatment
prophylactic
Prior art date
Application number
SE9904132A
Other languages
Swedish (sv)
Inventor
Lars G Burman
Sture Karlsson
Thomas Aakerlund
Original Assignee
Sbl Vaccin Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sbl Vaccin Ab filed Critical Sbl Vaccin Ab
Priority to SE9904132A priority Critical patent/SE9904132D0/en
Publication of SE9904132D0 publication Critical patent/SE9904132D0/en
Priority to PCT/SE2000/002241 priority patent/WO2001035983A1/en
Priority to AU17480/01A priority patent/AU1748001A/en
Priority to EP00980184A priority patent/EP1229926A1/en
Priority to CA002402811A priority patent/CA2402811A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A pharmaceutical composition comprising a colon-specific delivery system and cysteine, cysteine derivatives and/or cysteine-containing compounds, is described. Examples of the active ingredients are cysteine, acetylcysteine, cystine and glutathione. The cysteine, cysteine derivatives and cysteine-containing compounds may be used in a medicament for therapeutic, prophylactic and relapse prophylactic treatment of <i>Clostridium difficile</i> associated diarrhea/disease. A method of therapeutic, prophylactic and relapse prophylactic treatment of <i>Clostridium difficile</i> associa ted diarrhea/disease is also disclosed.
SE9904132A 1999-11-16 1999-11-16 Pharmaceutical composition for treatment of diarrhea SE9904132D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9904132A SE9904132D0 (en) 1999-11-16 1999-11-16 Pharmaceutical composition for treatment of diarrhea
PCT/SE2000/002241 WO2001035983A1 (en) 1999-11-16 2000-11-15 Pharmaceutical composition for treatment of diarrhea
AU17480/01A AU1748001A (en) 1999-11-16 2000-11-15 Pharmaceutical composition for treatment of diarrhea
EP00980184A EP1229926A1 (en) 1999-11-16 2000-11-15 Pharmaceutical composition for treatment of diarrhea
CA002402811A CA2402811A1 (en) 1999-11-16 2000-11-15 Pharmaceutical composition for treatment of diarrhea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904132A SE9904132D0 (en) 1999-11-16 1999-11-16 Pharmaceutical composition for treatment of diarrhea

Publications (1)

Publication Number Publication Date
SE9904132D0 true SE9904132D0 (en) 1999-11-16

Family

ID=20417728

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904132A SE9904132D0 (en) 1999-11-16 1999-11-16 Pharmaceutical composition for treatment of diarrhea

Country Status (5)

Country Link
EP (1) EP1229926A1 (en)
AU (1) AU1748001A (en)
CA (1) CA2402811A1 (en)
SE (1) SE9904132D0 (en)
WO (1) WO2001035983A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008139947A1 (en) * 2007-05-08 2008-11-20 Ajinomoto Co., Inc. Prophylactic or therapeutic agent for diarrhea
GB2527802B (en) * 2014-07-02 2019-10-16 Olimed Ltd An orally disintegrating tablet with differentiated absorption
US20220096510A1 (en) 2018-08-17 2022-03-31 Universidad Andrés Bello Method and pharmacological composition for the prevention of recurrent infections caused by clostridium difficile
WO2023079335A1 (en) 2021-11-03 2023-05-11 Universidad Andrés Bello Composition based on nystatin and vancomycin nanoparticles for the treatment of clostridioides difficile infection and prevention of recurrence

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587265A (en) * 1983-02-07 1986-05-06 St. Louis University Inhibition of diarrhea induced by Escherichia coli heat-stable enterotoxin
AU4701593A (en) * 1993-07-22 1995-02-20 Esseti S.A.S. Laboratorio Chimico Farmaco Biologico Di A. Ievoli & C. Oral pharmaceutical compositions comprising reduced glutathion
JP2001524087A (en) * 1997-04-18 2001-11-27 クリンゲ ファーマ ジーエムビーエイチ Stabilized drugs containing cysteinyl derivatives

Also Published As

Publication number Publication date
CA2402811A1 (en) 2001-05-25
AU1748001A (en) 2001-05-30
WO2001035983A1 (en) 2001-05-25
EP1229926A1 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
NO971889D0 (en) Compounds and compositions for delivery of active agents
BR9912694A (en) Compound to prepare pulmonary administration medication
NO965012D0 (en) A pharmaceutical composition comprising glucagon
AU2001288460A1 (en) Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant
IT1312377B1 (en) COMPOSITIONS BASED ON TIOTIC ACID, CISTEIN AND / OR N-ACETYL CISTEINADA USE IN PHARMACEUTICAL, DIETETIC AND COSMETIC PREPARATIONS
GEP20053602B (en) Aripiprazole for Oral Administration
PT1311285E (en) Liquid pharmaceutical composition containing a derivative of erythropoietin
AU7207098A (en) Stabilization of acid sensitive benzimidazols with amino acid/cyclodextrin combinations
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
AR037490A1 (en) SOLID PHARMACEUTICAL COMPOSITIONS, PROCESS FOR PREPARATION, KIT FOR THE TREATMENT OF OBESITY AND USE OF SUCH COMPOSITIONS IN THE DEVELOPMENT OF MEDICINES
ATE311227T1 (en) FAST-ACTING, FREEZE-DRIED, ORAL, PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF MIGRAINE
DE60019334D1 (en) ANTIVIRAL ARZNEI
WO2003028757A1 (en) Novel method of inducing antigen-specific t cells
WO2003028758A1 (en) Novel method of inducing antigen-specific t cells
DK1280558T3 (en) Semi-solid administration vehicle and pharmaceutical compositions
MXPA04003526A (en) Composition and method for treating diabetes.
SE9904132D0 (en) Pharmaceutical composition for treatment of diarrhea
ATE395064T1 (en) COMBINATION PREPARATIONS OF 3-N-FORMYLHYDROXYLAMINOPROPYLPHOSPHONY ACID DERIVATIVES OR 3-N-ACETYLHYDROXYLAMINOPROPYLPHOSPHONY ACID DERIVATIVES WITH SPECIAL PHARMACEUTICAL ACTIVE INGREDIENTS
MXPA02011533A (en) NOVEL FORMULATIONS OF agr; 2, 4 DISULFOPHENYL N TERT BUTYLNITRONE.
DE50114335D1 (en) LH-RH ANTAGONISTS, THEIR PREPARATION AND THEIR USE AS DRUGS
NO20000424D0 (en) Streptogramins, their preparation and preparations containing the compounds
SE9902742D0 (en) New pharmaceutical formultion
SE9800905L (en) New therapy with glomerulonephritis
DE60112578D1 (en) PHARMACEUTICAL DICLOFENAC COMPOUND BASED ON VITAMIN E, PAPAIN AND HYALURONIDASE
DE69902925T2 (en) New injectable medicinal preparations containing RAMOPLAN